These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8429302)

  • 21. Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.
    Tanaka Y; Tanaka R; Terada E; Koyanagi Y; Miyano-Kurosaki N; Yamamoto N; Baba E; Nakamura M; Shida H
    J Virol; 1994 Oct; 68(10):6323-31. PubMed ID: 8083972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical involvement of human T cell leukaemia virus type I virions in mediating the viral mitogenic effect.
    Cassé H; Girerd Y; Gazzolo L; Duc Dodon M
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():1909-16. PubMed ID: 8046393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity of human T cell leukemia virus type-I (HTLV-I) antigens for cytotoxic T lymphocytes in the rat system.
    Tanaka Y; Isobe A; Masuda M; Tozawa H; Koyanagi Y; Yamamoto N; Shida H
    J Immunol; 1991 Nov; 147(10):3646-52. PubMed ID: 1940363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and protective efficacy of recombinant human T-cell leukemia/lymphoma virus type 1 NYVAC and naked DNA vaccine candidates in squirrel monkeys (Saimiri sciureus).
    Kazanji M; Tartaglia J; Franchini G; de Thoisy B; Talarmin A; Contamin H; Gessain A; de Thé G
    J Virol; 2001 Jul; 75(13):5939-48. PubMed ID: 11390595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Production of HTLV-II env protein and its suppressive effect on infection].
    Kawamura N
    Hokkaido Igaku Zasshi; 1995 Jul; 70(4):635-47. PubMed ID: 7590608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay.
    Okuma K; Nakamura M; Nakano S; Niho Y; Matsuura Y
    Virology; 1999 Feb; 254(2):235-44. PubMed ID: 9986790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunodominant sites of human T cell lymphotropic virus type 1 envelope protein for murine helper T cells.
    Kurata A; Palker TJ; Streilein RD; Scearce RM; Haynes BF; Berzofsky JA
    J Immunol; 1989 Sep; 143(6):2024-30. PubMed ID: 2528586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycosylation-dependent peptide antigenic determinants of env gp46 HTLV-1.
    Kaumaya PT; Conrad SF; DiGeorge AM; Lairmore MD
    Leukemia; 1995 Oct; 9 Suppl 1():S133-8. PubMed ID: 7475306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification of envelope glycoproteins of human T cell lymphotropic virus type I (HTLV-I) by affinity chromatography.
    Palker TJ; Clark ME; Sarngadharan MG; Matthews TJ
    J Virol Methods; 1987 Dec; 18(4):243-55. PubMed ID: 2832431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
    Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
    J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid generation of antibodies against the HTLV-II external envelope protein by growth of mouse plasmacytomas in SCID mice.
    Li QX; Camerini D; Kuritzkes DR; Chen IS
    Virology; 1995 Dec; 214(2):680-4. PubMed ID: 8553576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.
    Kuroki M; Nakamura M; Itoyama Y; Tanaka Y; Shiraki H; Baba E; Esaki T; Tatsumoto T; Nagafuchi S; Nakano S
    J Immunol; 1992 Aug; 149(3):940-8. PubMed ID: 1378869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice.
    Yang DK; Kweon CH; Kim BH; Lim SI; Kwon JH; Kim SH; Song JY; Han HR
    J Vet Sci; 2005 Jun; 6(2):125-33. PubMed ID: 15933432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of neutralizing antibodies against bovine leukosis virus in rabbits by vaccination with recombinant vaccinia virus expressing bovine leukosis virus envelope glycoprotein.
    Ohishi K; Suzuki H; Maruyama T; Yamamoto T; Funahashi S; Miki K; Ikawa Y; Sugimoto M
    Am J Vet Res; 1990 Aug; 51(8):1170-3. PubMed ID: 2167028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly attenuated HTLV type Ienv poxvirus vaccines induce protection against a cell-associated HTLV type I challenge in rabbits.
    Franchini G; Tartaglia J; Markham P; Benson J; Fullen J; Wills M; Arp J; Dekaban G; Paoletti E; Gallo RC
    AIDS Res Hum Retroviruses; 1995 Feb; 11(2):307-13. PubMed ID: 7742044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amino acid changes at positions 173 and 187 in the human T-cell leukemia virus type 1 surface glycoprotein induce specific neutralizing antibodies.
    Blanchard S; Astier-Gin T; Tallet B; Moynet D; Londos-Gagliardi D; Guillemain B
    J Virol; 1999 Nov; 73(11):9369-76. PubMed ID: 10516045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recognition of human T cell leukemia virus type I (HTLV-I) gag and pX gene products by MHC-restricted cytotoxic T lymphocytes induced in rats against syngeneic HTLV-I-infected cells.
    Tanaka Y; Tozawa H; Koyanagi Y; Shida H
    J Immunol; 1990 Jun; 144(11):4202-11. PubMed ID: 2187927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunization against the human immunodeficiency virus in Zaire].
    Zagury D; Salaün JJ; Bernard J; Dechazal L; Goussard B; Lurhuma Z
    Med Trop (Mars); 1988; 48(4):417-23. PubMed ID: 3221792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A chimeric human T cell leukemia virus type I bearing a deltaR Moloney-murine leukemia virus envelope infects mice persistently and induces humoral and cellular immune responses.
    Delebecque F; Combredet C; Gabet AS; Wattel E; Brahic M; Tangy F
    J Infect Dis; 2005 Jan; 191(2):255-63. PubMed ID: 15609236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recognition of human T-leukemia virus (HTLV-1) envelope by human CD4+ T-cell lines from HTLV-1 seronegative individuals: specificity and clonal heterogeneity.
    Manca F; Li Pira G; Fenoglio D; Valle MT; Kunkl A; Ferraris A; Lancia F; Saverino D; Mortara L; Balderas R
    Blood; 1995 Mar; 85(6):1547-54. PubMed ID: 7534136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.